Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory Diseases

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this validation study is to provide further evidence of the metrological properties of the 6-minute stepper test in individuals with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD). The main questions it aims to answer are: 1. Is the 6-minute stepper test valid when compared to the 6-minute walk test and a maximal cardiopulmonary cycling test? 2. Does the 6-minute stepper test give the same results when conducted through direct (i.e., therapist in person) and remote (i.e., videoconferencing) monitoring? 3. Is the 6-minute stepper test safe when conducted at the home of the individual with direct (i.e., therapist in person) or remote (i.e., videoconferencing) monitoring? Participants will: * Conduct the 6-minute stepper test (several trials on separate days) * Conduct the 6-minute walk test (1 trial on 1 day) * Conduct a maximal cardiopulmonary test on a cycle ergometer (1 trial on 1 day) * Participate in a semi-structured interview to provide their feedback with regards to the 6-minute stepper test

Who May Be Eligible (Plain English)

Who May Qualify: - Adult ≥ 40 years old - Diagnosis of chronic obstructive pulmonary disease (GOLDa 2 to 4) or of interstitial lung disease (\> 6 months) - Clinically stable for ≥ 4 weeks Who Should NOT Join This Trial: - Interstitial lung disease associated with connective tissue disease and sarcoidosis (often accompanied with multisystemic effects) - Unstable or severe cardiac condition - Invalidating rheumatologic or neurologic condition - Weight exceeding maximal limits of exercise equipment (e.g., 130 kg for the stepper) - Any other physical condition limiting or contraindicating exercise testing - Simultaneous participation in another study requiring changes in medication - Recent pulmonary rehabilitation (≤1 year, potential learning bias for the 6-minute walk test and the 6-minute stepper test) - For arm 1 only: Use of oxygen therapy (unable to perform gas analysis with oxygen therapy) - For arm 2 only: Participation in arm 1 Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Adult ≥ 40 years old * Diagnosis of chronic obstructive pulmonary disease (GOLDa 2 to 4) or of interstitial lung disease (\> 6 months) * Clinically stable for ≥ 4 weeks Exclusion Criteria: * Interstitial lung disease associated with connective tissue disease and sarcoidosis (often accompanied with multisystemic effects) * Unstable or severe cardiac condition * Invalidating rheumatologic or neurologic condition * Weight exceeding maximal limits of exercise equipment (e.g., 130 kg for the stepper) * Any other physical condition limiting or contraindicating exercise testing * Simultaneous participation in another study requiring changes in medication * Recent pulmonary rehabilitation (≤1 year, potential learning bias for the 6-minute walk test and the 6-minute stepper test) * For arm 1 only: Use of oxygen therapy (unable to perform gas analysis with oxygen therapy) * For arm 2 only: Participation in arm 1

Locations (3)

Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval
Québec, Canada
Groupement des Hôpitaux de l'Institut Catholique de Lille
Lille, Hauts-de-France, France
FormAction Santé
Pérenchies, Hauts-de-France, France